With the ever-increasing range of LABA/corticosteroid asthma combination inhalers, including three devices launched just this year, the new MIMS table allows a quick comparison of all the possible options.
The table provides essential information for healthcare professionals prescribing a LABA/corticosteroid combination device for the first time, either when stepping up treatment in patients not adequately controlled on an inhaled corticosteroid and a short-acting β2 agonist, or when starting a combination inhaler in patients already adequately controlled on a LABA and a corticosteroid taken separately.
It is also designed to help prescribers looking for an alternative LABA/corticosteroid device where the existing choice is unsuitable.
The table summarises the following key information:
- Metered/pre-dispensed and delivered doses
- Inhaler type (breath-actuated or pressurised metered-dose)
- Dose counter and confirmation features
- Compatible spacers
- Age range for use
- Suitability for combined maintenance and reliever therapy.
All currently available LABA/corticosteroid inhalers are included, and the table will be updated as further products become available.